Cognition Therapeutics, Inc. ( CGTX) - Key Metrics
CGTX Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0 | -$0.04 | -$0.03 | -$0.03 |
| 2026Q1 | $0 | -$0.05 | -$0.06 | -$0.06 |
| 2025Q4 | $0 | -$0.04 | -$0.04 | -$0.04 |
| 2025Q3 | $0 | -$0.06 | -$0.07 | -$0.07 |
| 2025Q2 | $0 | -$0.11 | -$0.09 | -$0.09 |
CGTX Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -7.19 |
| 2026Q1 | 0% | -3.71 |
| 2025Q4 | 0% | -8.98 |
| 2025Q3 | 0% | -5.34 |
| 2025Q2 | 0% | -0.70 |
CGTX
Price: $0.73
52 week price:
Earnings Per Share: -0.17 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 239600
Market Capitalization: 84.0 million